MIRUM PHARMACEUTICALS, INC.
Profile
Company Names
MIRUM PHARMACEUTICALS, INC.
Addresses
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA 94404
950 TOWER LANE, SUITE 1050, FOSTER CITY, CA 94404
12230 EL CAMINO REAL, SUITE 230, SAN DIEGO, CA 92130
Phone Numbers
650-667-4085
619-733-3852
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2018
State Incorporated:
DELAWARE
Total Amount Raised:
$138,543,750.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2026-01-23
$68,480,000.00
$68,480,000.00
$0.00
Equity
2
2020-12-22
$10,000,000.00
$10,000,000.00
$0.00
Equity
1
2018-11-05
$60,063,750.00
$120,063,750.00
$60,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIBA
AYNECHI
DIRECTOR
THESAN PHARMACEUTICALS, INC.
| IRHYTHM TECHNOLOGIES, INC.
| ANAPTYSBIO INC
| GENOA PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| ARCELLX, INC.
| NKARTA, INC.
| AVALYN PHARMA INC.
| SPRUCE BIOSCIENCES, INC.
| ARISTEA THERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
| REZO THERAPEUTICS, INC.
| RAY THERAPEUTICS, INC.
ERIC
BJERKHOLT
EXECUTIVE OFFICER
LAURA
BREGE
DIRECTOR
IAN
CLEMENTS
EXECUTIVE OFFICER
SUSAN
DUBE
EXECUTIVE OFFICER
LAURENT
FISCHER
DIRECTOR
MICHAEL
GREY
EXECUTIVE OFFICER, DIRECTOR
AUSPEX PHARMACEUTICALS, INC.
| ACHILLION PHARMACEUTICALS INC
| LUMENA PHARMACEUTICALS, INC.
| SELVENTA, INC.
| HORIZON PHARMA, INC.
| BALANCE THERAPEUTICS, INC.
| AMPLYX PHARMACEUTICALS, INC.
| RENEO PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| SPRUCE BIOSCIENCES, INC.
| SORRISO PHARMACEUTICALS, INC.
| PLEXIUM, INC.
PATRICK
HERON
DIRECTOR
QUATRX PHARMACEUTICALS CO
| TRUBION PHARMACEUTICALS, INC
| COLLEGIUM PHARMACEUTICAL INC
| VENTIRX PHARMACEUTICALS INC
| TOBIRA THERAPEUTICS, INC.
| KALIDEX PHARMACEUTICALS, INC.
| PRECISION DERMATOLOGY, INC.
| INFORMED MEDICAL COMMUNICATIONS, INC.
| SILVERGATE PHARMACEUTICALS, INC.
| VENTIRX PHARMACEUTICALS INC.
| FRAZIER HEALTHCARE VII-A, L.P.
| FRAZIER HEALTHCARE VII, L.P.
| K2 THERAPEUTICS, INC.
| IMAGO BIOSCIENCES, INC.
| COLLEGIUM PHARMACEUTICAL, INC
| CIDARA THERAPEUTICS, INC.
| NEXCIDA THERAPEUTICS, INC.
| ITERUM THERAPEUTICS LTD
| ZAVANTE THERAPEUTICS, INC.
| SUTROVAX, INC.
| SCOUT BIO, INC.
| RECIDA THERAPEUTICS, INC.
| MIRUM PHARMACEUTICALS, INC.
| PASSAGE BIO, INC.
| ARCUTIS BIOTHERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
PATRICK
J.
HERON
DIRECTOR
FRAZIER LIFE SCIENCES VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES VIII, L.P.
| ITERUM THERAPEUTICS LTD
| FRAZIER LIFE SCIENCES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX PV, L.P.
| IMAGO BIOSCIENCES, INC.
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| MIRUM PHARMACEUTICALS, INC.
| FRAZIER LIFE SCIENCES XI, L.P.
JONATHAN
LEFF
DIRECTOR
HANA BIOSCIENCES INC
| RIB X PHARMACEUTICALS INC
| TALON THERAPEUTICS, INC.
| N30 PHARMACEUTICALS, INC.
| AUDENTES THERAPEUTICS, INC.
| AVEXIS, INC.
| APRECIA PHARMACEUTICALS CO
| PROTEON THERAPEUTICS INC
| DRACEN PHARMACEUTICALS, INC.
| ARS PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC
| LARIMAR THERAPEUTICS, INC.
| AVALYN PHARMA INC.
| AEROVATE THERAPEUTICS, INC.
| ADAPTIVE PHAGE THERAPEUTICS, INC.
| INNERVACE, INC.
| BIOMX INC.
| ELION THERAPEUTICS, INC.
| AXONIS THERAPEUTICS, INC.
ED
MATHERS
DIRECTOR
LIQUIDIA TECHNOLOGIES INC
| INTARCIA THERAPEUTICS, INC
| ENVISIA THERAPEUTICS INC.
| SYNLOGIC, INC.
| MIRNA THERAPEUTICS, INC.
| AMPLYX PHARMACEUTICALS, INC.
| ENVISIA THERAPEUTICS, INC.
| SYNLOGIC, LLC
| TREVI THERAPEUTICS, INC.
| AKOUOS, INC.
| RENEO PHARMACEUTICALS, INC.
| SENTI BIOSCIENCES, INC.
| MIRUM PHARMACEUTICALS, INC.
| CURZION PHARMACEUTICALS, INC.
EDWARD
T.
MATHERS
DIRECTOR
RHYTHM METABOLIC, INC.
| RHYTHM PHARMACEUTICALS, INC.
| NEA BH SPV, L.P.
| NEA BH SPV II, L.P.
| MIRUM PHARMACEUTICALS, INC.
| NEW ENTERPRISE ASSOCIATES 18, L.P.
| NEA 18 VENTURE GROWTH EQUITY, L.P.
| NEA SH SPV, L.P.
| NEA RP SPV, L.P.
| NEA CH SPV, L.P.
| NEA TS 2024 SPV, L.P.
| NEA SECONDARY OPPORTUNITY FUND, L.P.
| ONKURE THERAPEUTICS, INC.
NIALL
O-DONNELL
DIRECTOR
LYRIC PHARMACEUTICALS INC.
| 3X5 RIVERVEST FUND II, L.P.
| ARCHER SEED FUND, L.P.
| GENOA PHARMACEUTICALS, INC.
| RENEO PHARMACEUTICALS, INC.
| RIVERVEST VENTURE FUND IV, L.P.
| CURZION PHARMACEUTICALS, INC.
| SPRUCE BIOSCIENCES, INC.
| AVALYN PHARMA INC.
| MIRUM PHARMACEUTICALS, INC.
| RIVERVEST VENTURE FUND V, L.P.
| SPARROW PHARMACEUTICALS, INC.
| WUGEN, INC.
CHRISTOPHER
PEETZ
EXECUTIVE OFFICER, DIRECTOR
SAIRA
RAMASASTRY
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-01-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-12-22
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

